Skip to content

Nasdaq · CIK 0001645113

NVCR NovoCure Ltd

Insider trading from SEC Form 4. Last filing Mar 5, 2026. Close $14.58 on Oct 9, 2026, +45% from the 52-week low and -27% from the high.

Last 90 days

Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
18
with a Form 4 at this company

Price and insider trades, last year

NVCROct 9, 2026 · close 14.58

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

Open-market buys and sells at NovoCure Ltd, scored.

ScoreInsiderValueHoldingsPrice contextFiled
46ModerateChristoph Brackmann
Chief Financial Officer
sell
$85k
6,412 shares
-3%+34% from low-37% from high
64NotableWilliam F Doyle
Executive Chairman
sell
$933k
71,887 shares
-18%+33% from low-38% from high
48ModerateFrank X Leonard
Chief Executive Officer
sell
$75k
5,607 shares
-1%+34% from low-37% from high
30WeakNicolas Leupin
Former Chief Medical Officer
sell
$15k
1,100 shares
-1%+34% from low-37% from high
39WeakUri Weinberg
Chf Medical and Innovation Ofr
sell
$85k
6,412 shares
-2%+34% from low-37% from high
30WeakMichal Nath Puri
Chief Human Resources Officer
sell
$15k
1,100 shares
-1%+34% from low-37% from high
65NotableMukund Paravasthu
Chief Operating Officer
sell
$667k
48,623 shares
-40%+34% from low-37% from high
53ModerateFrank X Leonard
Chief Executive Officer
sell
$231k
16,966 shares
-5%+36% from low-36% from high
30WeakNicolas Leupin
Former Chief Medical Officer
sell
$14k
1,029 shares
-1%+36% from low-36% from high
41ModerateUri Weinberg
Chf Medical and Innovation Ofr
sell
$147k
10,733 shares
-5%+36% from low-36% from high
30WeakMichal Nath Puri
Chief Human Resources Officer
sell
$20k
1,441 shares
-1%+36% from low-36% from high
40ModerateMukund Paravasthu
Chief Operating Officer
sell
$27k
1,963 shares
-3%+36% from low-36% from high
64NotableAshley Cordova
Chief Executive Officer
buy
$997k
81,550 shares
+23%+13% from low-63% from high
56ModerateChristoph Brackmann
Chief Financial Officer
buy
$232k
20,000 shares
+17%0% from low-66% from high
35WeakJeryl L Hilleman
director
sell
$17k
999 shares
-15%+17% from low-49% from high
30WeakDavid Hung
director
sell
$17k
999 shares
-8%+17% from low-49% from high
30WeakGabriel Leung
director
sell
$17k
999 shares
-1%+17% from low-49% from high
33WeakFrank X Leonard
EVP, Pres., Novocure Oncology
sell
$528k
30,196 shares
-15%+17% from low-49% from high
30WeakMartin J. Madden
director
sell
$17k
999 shares
-5%+17% from low-49% from high
30WeakW Anthony Vernon
director
sell
$17k
999 shares
-1%+17% from low-49% from high
35WeakAllyson J Ocean
director
sell
$17k
999 shares
-25%+17% from low-49% from high
35WeakTimothy J Scannell
director
sell
$17k
999 shares
-14%+17% from low-49% from high
35WeakKristin Stafford
director
sell
$17k
999 shares
-25%+17% from low-49% from high
20WeakMukund Paravasthu
Chief Operating Officer
sell
$11k
592 shares
-1%+25% from low-46% from high
31WeakAshley Cordova
Chief Executive Officer
sell
$38k
2,053 shares
-1%-
38WeakAshley Cordova
Chief Executive Officer
sell
$266k
13,494 shares
-6%-
35WeakMukund Paravasthu
Chief Operating Officer
sell
$734
44 shares
-1%-
30WeakFrank X Leonard
EVP, Pres., Novocure Oncology
sell
$9,531
598 shares
-0%-
35WeakMukund Paravasthu
Chief Operating Officer
sell
$2,540
160 shares
-4%-
30WeakMichal Nath Puri
Chief Human Resources Officer
sell
$13k
810 shares
-1%-

Planned sales

Form 144 notices filed before a sale of restricted or control stock, newest first. The sale itself usually reaches a Form 4 within days. All planned sales

FiledSellerSharesValueSale datePast 3 months
Jun 2, 2025 FRANCIS LEONARD
Officer
30,196
0.03% of outstanding
$577kJun 2, 2025$47k
May 5, 2025 MUKUND PARAVASTHU
Officer
592
0.00% of outstanding
$11kMay 5, 2025$44k
Mar 3, 2025 ASHLEY CORDOVA
Officer
2,053
0.00% of outstanding
$38kMar 3, 2025$266k
Mar 3, 2025 WILHELMUS GROENHUYSEN
Officer
3,165
0.00% of outstanding
$59kMar 3, 2025$7.2M
Mar 3, 2025 FRANCIS LEONARD
Officer
2,527
0.00% of outstanding
$47kMar 3, 2025$296k
Mar 3, 2025 URI WEINBERG
Officer
268
0.00% of outstanding
$5,071Mar 3, 2025$87k
Mar 3, 2025 MUKUND PARAVASTHU
Officer
250
0.00% of outstanding
$4,634Mar 3, 2025$97k
Feb 28, 2025 ASHLEY CORDOVA
Officer
2,341
0.00% of outstanding
$43kFeb 28, 2025$223k
Feb 28, 2025 WILHELMUS GROENHUYSEN
Officer
3,202
0.00% of outstanding
$59kFeb 28, 2025$7.1M
Feb 28, 2025 FRANCIS LEONARD
Officer
2,770
0.00% of outstanding
$51kFeb 28, 2025$246k
Feb 28, 2025 MUKUND PARAVASTHU
Officer
368
0.00% of outstanding
$6,729Feb 28, 2025$91k
Feb 28, 2025 URI WEINBERG
Officer
4,637
0.00% of outstanding
$87kFeb 28, 2025none
Feb 27, 2025 ASHLEY CORODVA
Officer
11,153
0.01% of outstanding
$223kFeb 27, 2025none
Feb 27, 2025 WILHELMUS GROENHUYSEN
Officer
7,211
0.01% of outstanding
$144kFeb 27, 2025$7.0M
Feb 27, 2025 FRANCIS LEONARD
Officer
12,266
0.01% of outstanding
$246kFeb 27, 2025none
Feb 27, 2025 MUKUND PARAVASTHU
Officer
1,646
0.00% of outstanding
$33kFeb 27, 2025$58k
Jan 13, 2025 MUKUND PARAVASTHU
Officer
2,160
0.00% of outstanding
$58kJan 13, 2025$3,276
Jan 2, 2025 WILHELMUS C. GROENHUYSEN
Officer
266,085
0.25% of outstanding
$7.9MJan 2, 2025none

Transactions

The last 100 rows filed, every code.

DateInsiderTransactionSharesPriceValueHoldings afterFiled
Mar 3, 2026Uri Weinberg
Chf Medical and Innovation Ofr
AGrant or award
Ordinary Shares
+50,125$0.00$0273,602Mar 5, 2026
Mar 3, 2026Christoph Brackmann
Chief Financial Officer
AGrant or award
Ordinary Shares
+55,137$0.00$0189,254Mar 5, 2026
Mar 3, 2026Frank X Leonard
Chief Executive Officer
AGrant or award
Ordinary Shares
+150,000$0.00$0499,400Mar 5, 2026
Mar 3, 2026Michal Nath Puri
Chief Human Resources Officer
AGrant or award
Ordinary Shares
+40,100$0.00$0202,422Mar 5, 2026
Mar 3, 2026William F Doyle
Executive Chairman
AGrant or award
Ordinary Shares
+200,000$0.00$0200,000Mar 5, 2026
Mar 4, 2026Nicolas Leupin
Former Chief Medical Officer
SOpen-market sale
Ordinary Shares
-1,100$13.31$15k102,979Mar 5, 2026
Mar 3, 2026Mukund Paravasthu
Chief Operating Officer
AGrant or award
Ordinary Shares
+45,112$0.00$0121,455Mar 5, 2026
Mar 4, 2026Ashley Cordova
Former Chief Executive Officer
FTax withholding
Ordinary Shares
-17,638$13.30$235k422,570Mar 5, 2026
Mar 3, 2026Arye Barak Ben
General Counsel
AGrant or award
Ordinary Shares
+50,125$0.00$0242,453Mar 5, 2026
Mar 4, 2026Mukund Paravasthu
Chief Operating Officer
SOpen-market sale
Ordinary Shares
-5,377$13.31$72k116,078Mar 5, 2026
Mar 4, 2026Michal Nath Puri
Chief Human Resources Officer
SOpen-market sale
Ordinary Shares
-1,100$13.31$15k201,322Mar 5, 2026
Mar 4, 2026Frank X Leonard
Chief Executive Officer
SOpen-market sale
Ordinary Shares
-5,607$13.31$75k493,793Mar 5, 2026
Mar 3, 2026Arye Barak Ben
General Counsel
AGrant or award
Stock Option (Right to Buy)derivative
+73,340$0.00$073,340Mar 5, 2026
Mar 3, 2026William F Doyle
Executive Chairman
AGrant or award
Ordinary Shares
+200,284$0.00$0400,284Mar 5, 2026
Mar 4, 2026Christoph Brackmann
Chief Financial Officer
SOpen-market sale
Ordinary Shares
-6,412$13.31$85k182,842Mar 5, 2026
Mar 4, 2026Uri Weinberg
Chf Medical and Innovation Ofr
SOpen-market sale
Ordinary Shares
-6,412$13.31$85k267,190Mar 5, 2026
Mar 3, 2026William F Doyle
Executive Chairman
SOpen-market sale
Ordinary Shares
-50,557$12.79$646k349,727Mar 5, 2026
Mar 3, 2026Uri Weinberg
Chf Medical and Innovation Ofr
AGrant or award
Stock Option (Right to Buy)derivative
+73,340$0.00$073,340Mar 5, 2026
Mar 5, 2026Mukund Paravasthu
Chief Operating Officer
SOpen-market sale
Ordinary Shares
-43,246$13.77$596k72,832Mar 5, 2026
Mar 3, 2026Christoph Brackmann
Chief Financial Officer
AGrant or award
Stock Option (Right to Buy)derivative
+80,674$0.00$080,674Mar 5, 2026
Mar 3, 2026Frank X Leonard
Chief Executive Officer
AGrant or award
Stock Option (Right to Buy)derivative
+216,388$0.00$0216,388Mar 5, 2026
Mar 3, 2026Michal Nath Puri
Chief Human Resources Officer
AGrant or award
Stock Option (Right to Buy)derivative
+58,672$0.00$058,672Mar 5, 2026
Mar 3, 2026Mukund Paravasthu
Chief Operating Officer
AGrant or award
Stock Option (Right to Buy)derivative
+7,518$0.00$07,518Mar 5, 2026
Mar 3, 2026William F Doyle
Executive Chairman
SOpen-market sale
Ordinary Shares
-21,330$13.43$286k328,397Mar 5, 2026
Mar 3, 2026William F Doyle
Executive Chairman
AGrant or award
Stock Option (Right to Buy)derivative
+258,445$0.00$0258,445Mar 5, 2026
Mar 3, 2026Mukund Paravasthu
Chief Operating Officer
AGrant or award
Stock Option (Right to Buy)derivative
+58,488$0.00$066,006Mar 5, 2026
Mar 3, 2026William F Doyle
Executive Chairman
AGrant or award
Stock Option (Right to Buy)derivative
+30,072$0.00$0288,517Mar 5, 2026
Feb 28, 2026Arye Barak Ben
General Counsel
AGrant or award
Ordinary Shares
+17,755$0.00$0192,328Mar 3, 2026
Feb 27, 2026Ashley Cordova
Former Chief Executive Officer
FTax withholding
Ordinary Shares
-11,541$13.75$159k426,028Mar 3, 2026
Feb 27, 2026Frank X Leonard
Chief Executive Officer
SOpen-market sale
Ordinary Shares
-9,734$13.66$133k338,011Mar 3, 2026
Feb 27, 2026Nicolas Leupin
Former Chief Medical Officer
SOpen-market sale
Ordinary Shares
-1,029$13.66$14k104,079Mar 3, 2026
Feb 27, 2026Uri Weinberg
Chf Medical and Innovation Ofr
SOpen-market sale
Ordinary Shares
-7,461$13.84$103k213,757Mar 3, 2026
Feb 27, 2026Michal Nath Puri
Chief Human Resources Officer
SOpen-market sale
Ordinary Shares
-1,441$13.66$20k162,322Mar 3, 2026
Feb 27, 2026Mukund Paravasthu
Chief Operating Officer
SOpen-market sale
Ordinary Shares
-1,555$13.66$21k76,751Mar 3, 2026
Feb 28, 2026Ashley Cordova
Former Chief Executive Officer
AGrant or award
Ordinary Shares
+23,818$0.00$0449,846Mar 3, 2026
Feb 28, 2026Frank X Leonard
Chief Executive Officer
AGrant or award
Ordinary Shares
+18,621$0.00$0356,632Mar 3, 2026
Feb 28, 2026Uri Weinberg
Chf Medical and Innovation Ofr
AGrant or award
Ordinary Shares
+12,992$0.00$0226,749Mar 3, 2026
Mar 2, 2026Mukund Paravasthu
Chief Operating Officer
SOpen-market sale
Ordinary Shares
-408$13.49$5,50576,343Mar 3, 2026
Mar 2, 2026Ashley Cordova
Former Chief Executive Officer
FTax withholding
Ordinary Shares
-2,410$13.67$33k447,436Mar 3, 2026
Mar 2, 2026Frank X Leonard
Chief Executive Officer
SOpen-market sale
Ordinary Shares
-7,232$13.49$98k349,400Mar 3, 2026
Mar 2, 2026Uri Weinberg
Chf Medical and Innovation Ofr
SOpen-market sale
Ordinary Shares
-3,272$13.33$44k223,477Mar 3, 2026
Mar 2, 2026Ashley Cordova
Former Chief Executive Officer
FTax withholding
Ordinary Shares
-7,228$13.67$99k440,208Mar 3, 2026
Jan 11, 2026Mukund Paravasthu
Chief Operating Officer
FTax withholding
Ordinary Shares
-2,133$14.35$31k78,306Jan 12, 2026
Nov 4, 2025Christoph Brackmann
Chief Financial Officer
FTax withholding
Ordinary Shares
-7,033$12.23$86k134,117Nov 4, 2025
Nov 1, 2025Frank X Leonard
EVP, Pres., Novocure Oncology
FTax withholding
Ordinary Shares
-966$12.81$12k347,745Nov 4, 2025
Nov 1, 2025Mukund Paravasthu
Chief Operating Officer
FTax withholding
Ordinary Shares
-168$12.81$2,15283,388Nov 4, 2025
Oct 31, 2025Michal Nath Puri
Chief Human Resources Officer
FTax withholding
Ordinary Shares
-752$12.82$9,641163,762Nov 4, 2025
Nov 4, 2025Mukund Paravasthu
Chief Operating Officer
FTax withholding
Ordinary Shares
-2,949$12.23$36k80,439Nov 4, 2025
Sep 5, 2025Ashley Cordova
Chief Executive Officer
POpen-market purchase
Ordinary Shares
+81,550$12.22$997k437,569Sep 8, 2025
Jul 29, 2025Christoph Brackmann
Chief Financial Officer
POpen-market purchase
Ordinary Shares
+10,000$11.63$116k131,150Jul 30, 2025
Jul 29, 2025Christoph Brackmann
Chief Financial Officer
POpen-market purchase
Ordinary Shares
+5,000$11.60$58k136,150Jul 30, 2025
Jul 29, 2025Christoph Brackmann
Chief Financial Officer
POpen-market purchase
Ordinary Shares
+5,000$11.50$58k141,150Jul 30, 2025
Jun 30, 2025Arye Barak Ben
General Counsel
AGrant or award
Ordinary Shares
+769$15.13$12k174,465Jul 1, 2025
Jun 30, 2025Ashley Cordova
Chief Executive Officer
AGrant or award
Ordinary Shares
+833$15.13$13k356,019Jul 1, 2025
Jun 30, 2025Asaf Danziger
director
AGrant or award
Ordinary Shares
+833$15.13$13k416,473Jul 1, 2025
Jun 30, 2025Frank X Leonard
EVP, Pres., Novocure Oncology
AGrant or award
Ordinary Shares
+833$15.13$13k348,711Jul 1, 2025
Jun 30, 2025Michal Nath Puri
Chief Human Resources Officer
AGrant or award
Ordinary Shares
+833$15.13$13k164,514Jul 1, 2025
Jun 4, 2025Frank X Leonard
EVP, Pres., Novocure Oncology
AGrant or award
Ordinary Shares
+179,426$0.00$0347,878Jun 6, 2025
Jun 4, 2025Martin J. Madden
director
AGrant or award
Stock Option (Right to Buy)derivative
+33,393$0.00$033,393Jun 6, 2025
Jun 4, 2025W Anthony Vernon
director
AGrant or award
Ordinary Shares
+11,215$0.00$0179,102Jun 6, 2025
Jun 4, 2025Timothy J Scannell
director
AGrant or award
Ordinary Shares
+11,215$0.00$017,233Jun 6, 2025
Jun 4, 2025Allyson J Ocean
director
AGrant or award
Ordinary Shares
+11,215$0.00$014,269Jun 6, 2025
Jun 4, 2025Kristin Stafford
director
AGrant or award
Ordinary Shares
+11,215$0.00$014,269Jun 6, 2025
Jun 4, 2025Jeryl L Hilleman
director
AGrant or award
Ordinary Shares
+11,215$0.00$016,806Jun 6, 2025
Jun 4, 2025David Hung
director
AGrant or award
Ordinary Shares
+11,215$0.00$023,410Jun 6, 2025
Jun 4, 2025Gabriel Leung
director
AGrant or award
Ordinary Shares
+11,215$0.00$092,444Jun 6, 2025
Jun 4, 2025W Anthony Vernon
director
AGrant or award
Stock Option (Right to Buy)derivative
+16,697$0.00$016,697Jun 6, 2025
Jun 4, 2025Timothy J Scannell
director
AGrant or award
Stock Option (Right to Buy)derivative
+16,697$0.00$016,697Jun 6, 2025
Jun 4, 2025Allyson J Ocean
director
AGrant or award
Stock Option (Right to Buy)derivative
+16,697$0.00$016,697Jun 6, 2025
Jun 4, 2025Kristin Stafford
director
AGrant or award
Stock Option (Right to Buy)derivative
+16,697$0.00$016,697Jun 6, 2025
Jun 4, 2025Jeryl L Hilleman
director
AGrant or award
Stock Option (Right to Buy)derivative
+16,697$0.00$016,697Jun 6, 2025
Jun 4, 2025David Hung
director
AGrant or award
Stock Option (Right to Buy)derivative
+16,697$0.00$016,697Jun 6, 2025
Jun 4, 2025Gabriel Leung
director
AGrant or award
Stock Option (Right to Buy)derivative
+16,697$0.00$016,697Jun 6, 2025
Jun 3, 2025Jeryl L Hilleman
director
SOpen-market sale
Ordinary Shares
-999$17.26$17k5,591Jun 4, 2025
Jun 3, 2025David Hung
director
SOpen-market sale
Ordinary Shares
-999$17.30$17k12,195Jun 4, 2025
Jun 3, 2025Gabriel Leung
director
SOpen-market sale
Ordinary Shares
-999$17.31$17k81,229Jun 4, 2025
Jun 3, 2025Martin J. Madden
director
SOpen-market sale
Ordinary Shares
-999$17.19$17k18,674Jun 4, 2025
Jun 3, 2025W Anthony Vernon
director
SOpen-market sale
Ordinary Shares
-999$17.35$17k167,887Jun 4, 2025
Jun 3, 2025Allyson J Ocean
director
SOpen-market sale
Ordinary Shares
-999$17.29$17k3,054Jun 4, 2025
Jun 3, 2025Timothy J Scannell
director
SOpen-market sale
Ordinary Shares
-999$17.32$17k6,018Jun 4, 2025
Jun 3, 2025Kristin Stafford
director
SOpen-market sale
Ordinary Shares
-999$17.28$17k3,054Jun 4, 2025
Jun 2, 2025Frank X Leonard
EVP, Pres., Novocure Oncology
SOpen-market sale
Ordinary Shares10b5-1
-21,717$17.22$374k176,931Jun 4, 2025
Jun 2, 2025Frank X Leonard
EVP, Pres., Novocure Oncology
SOpen-market sale
Ordinary Shares10b5-1
-6,600$17.99$119k170,331Jun 4, 2025
Jun 2, 2025Frank X Leonard
EVP, Pres., Novocure Oncology
SOpen-market sale
Ordinary Shares10b5-1
-1,879$19.01$36k168,452Jun 4, 2025
May 3, 2025Mukund Paravasthu
Chief Operating Officer
SOpen-market sale
Ordinary Shares
-592$17.91$11k83,556May 5, 2025
Mar 4, 2025Arye Barak Ben
General Counsel
AGrant or award
Ordinary Shares
+54,975$18.19$1000k173,696Mar 6, 2025
Mar 4, 2025Christoph Brackmann
Chief Financial Officer
AGrant or award
Ordinary Shares
+54,975$18.19$1000k121,150Mar 6, 2025
Mar 4, 2025Ashley Cordova
Chief Executive Officer
AGrant or award
Ordinary Shares
+151,181$18.19$2.7M355,186Mar 6, 2025
Mar 4, 2025Arye Barak Ben
General Counsel
AGrant or award
Stock Options (Right to buy)derivative
+81,499$18.19$1.5M81,499Mar 6, 2025
Mar 4, 2025Christoph Brackmann
Chief Financial Officer
AGrant or award
Stock Options (Right to buy)derivative
+81,499$18.19$1.5M81,499Mar 6, 2025
Mar 4, 2025Ashley Cordova
Chief Executive Officer
AGrant or award
Stock Options (Right to buy)derivative
+224,123$18.19$4.1M224,123Mar 6, 2025
Mar 3, 2025Ashley Cordova
Chief Executive Officer
SOpen-market sale
Ordinary Shares
-2,053$18.54$38k204,005Mar 4, 2025
Feb 27, 2025Ashley Cordova
Chief Executive Officer
SOpen-market sale
Ordinary Shares
-9,345$19.92$186k210,207Mar 3, 2025
Feb 27, 2025Ashley Cordova
Chief Executive Officer
SOpen-market sale
Ordinary Shares
-1,808$20.55$37k208,399Mar 3, 2025
Feb 28, 2025Ashley Cordova
Chief Executive Officer
SOpen-market sale
Ordinary Shares
-2,341$18.28$43k206,058Mar 3, 2025
Dec 31, 2024Arye Barak Ben
General Counsel
AGrant or award
Ordinary Shares
+669$14.75$9,866118,721Jan 3, 2025
Dec 31, 2024Ashley Cordova
Chief Executive Officer
AGrant or award
Ordinary Shares
+373$14.75$5,501219,552Jan 3, 2025
Dec 31, 2024Asaf Danziger
director
AGrant or award
Ordinary Shares
+412$14.75$6,07615,640Jan 3, 2025
Jan 1, 2025Asaf Danziger
director
AGrant or award
Ordinary Shares
+400,000$0.00$0415,640Jan 3, 2025
Nov 2, 2024Mukund Paravasthu
Chief Operating Officer
SOpen-market sale
Ordinary Shares
-44$16.69$7343,459Nov 6, 2024

Insiders

Everyone who has filed a Form 4 here.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

NVCR insider trading: NovoCure Ltd | InsiderTell